X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
natural sciences (72) 72
naturvetenskap (72) 72
fysik (70) 70
physical sciences (70) 70
high energy physics - experiment (65) 65
physics (65) 65
experiment (59) 59
physics, particles & fields (56) 56
particle physics (50) 50
humans (48) 48
high energy physics (47) 47
physics - high energy physics - experiment (45) 45
female (42) 42
physics of elementary particles and fields (42) 42
index medicus (39) 39
detectors (28) 28
elementary particles, quantum field theory (27) 27
quantum field theories, string theory (27) 27
astronomy & astrophysics (24) 24
collisions (23) 23
astronomy, astrophysics and cosmology (22) 22
phenomenology (22) 22
subatomic physics (22) 22
subatomär fysik (22) 22
instrumentation and detectors (20) 20
middle aged (20) 20
nuclear experiment (20) 20
measurement science and instrumentation (19) 19
nuclear physics, heavy ions, hadrons (19) 19
large hadron collider (18) 18
obstetrics and gynecology (18) 18
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (17) 17
adult (17) 17
luminosity (16) 16
physics, nuclear (16) 16
aged (15) 15
cancer (15) 15
oncology (15) 15
ovarian cancer (14) 14
science & technology (14) 14
analysis (13) 13
animals (13) 13
ciências físicas [ciências naturais] (13) 13
decay (13) 13
endometrial cancer (13) 13
model (13) 13
nuclear energy (13) 13
parton distributions (13) 13
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (12) 12
expression (12) 12
instruments & instrumentation (12) 12
male (12) 12
particle physics - experiment (12) 12
chemotherapy (11) 11
cross sections (11) 11
detectors and experimental techniques (11) 11
engineering (11) 11
hadrons (11) 11
lhc (11) 11
muons (11) 11
particle collisions (11) 11
physics and astronomy (11) 11
research (11) 11
astrophysics (10) 10
health aspects (10) 10
ovarian neoplasms - genetics (10) 10
ovarian neoplasms - pathology (10) 10
protons (10) 10
standard model (10) 10
transverse momentum (10) 10
calibration (9) 9
cervical cancer (9) 9
genetic aspects (9) 9
hadron-hadron scattering (9) 9
higgs bosons (9) 9
high energy astrophysical phenomena (9) 9
leptons (9) 9
mutation (9) 9
neoplasm staging (9) 9
searching (9) 9
carcinoma (8) 8
classical and quantum gravitation, relativity theory (8) 8
endocrine system diseases (8) 8
endometrial neoplasms - surgery (8) 8
genetics & heredity (8) 8
jets (8) 8
prognosis (8) 8
quantum physics (8) 8
risk factors (8) 8
simulation (8) 8
studies (8) 8
tumors (8) 8
aged, 80 and over (7) 7
atlas (7) 7
breast cancer (7) 7
breast-cancer (7) 7
clinical medicine (7) 7
computer simulation (7) 7
electrons (7) 7
física (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 87 - 97
Summary Background The poly(ADP-ribose) polymerase inhibitor olaparib has shown antitumour activity in patients with platinum-sensitive, recurrent, high-grade... 
Hematology, Oncology and Palliative Medicine | LIPOSOMAL DOXORUBICIN | MULTICENTER | INHIBITION | SOLID TUMORS | CISPLATIN | ONCOLOGY | POLYMERASE | OPEN-LABEL | COMBINATION | CARCINOMA | MAINTENANCE THERAPY | Piperazines - administration & dosage | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Ovarian Neoplasms - mortality | Molecular Targeted Therapy | Enzyme Inhibitors - administration & dosage | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Time Factors | Antineoplastic Agents - adverse effects | Adult | Female | Neoplasms, Cystic, Mucinous, and Serous - drug therapy | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Enzyme Inhibitors - adverse effects | Neoplasms, Cystic, Mucinous, and Serous - pathology | Phthalazines - administration & dosage | Drug Administration Schedule | Administration, Oral | Neoplasm Recurrence, Local | Carboplatin - administration & dosage | Neoplasms, Cystic, Mucinous, and Serous - enzymology | Treatment Outcome | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors | Ovarian Neoplasms - enzymology | BRCA1 Protein - genetics | Disease-Free Survival | Administration, Intravenous | Poly(ADP-ribose) Polymerases - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Mutation | BRCA2 Protein - genetics | Neoplasms, Cystic, Mucinous, and Serous - mortality | Phthalazines - adverse effects | Relapse | Chemotherapy | Hospitals | Gene mutations | Sugars | Diseases | Cancer | Monosaccharides | Ovarian cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 928 - 936
Journal Article
Human Pathology, ISSN 0046-8177, 2015, Volume 46, Issue 5, pp. 739 - 745
Journal Article
Journal of Obstetrics and Gynaecology Canada (JOGC), ISSN 1701-2163, 2010, Volume 32, Issue 6, pp. S64 - S64
Journal Article
Best Practice & Research: Clinical Obstetrics & Gynaecology, ISSN 1521-6934, 2010, Volume 25, Issue 2, pp. 227 - 237
Women affected by early stage invasive cancer of the cervix are usually treated by surgery. Radical abdominal hysterectomy with pelvic lymphadenectomy is the... 
Obstetrics and Gynecology | radical hysterectomy | radical vaginal hysterectomy | cervical cancer | total laparoscopic radical hysterectomy
Journal Article
Journal of Obstetrics and Gynaecology Canada (JOGC), ISSN 1701-2163, 2010, Volume 32, Issue 6, pp. 570 - 579
Abstract Uterine cancer is the fourth most common cancer in Canadian women, with an estimated 4200 new cases and 790 disease-related deaths in 2008. We... 
Obstetrics and Gynecology | laparoscopy | cost | Endometrial cancer | minimally invasive surgery | complications | quality of life | Minimally invasive surgery | Laparoscopy | Complications | Cost | Quality of life | Length of Stay | Humans | Endometrial Neoplasms - surgery | Hysterectomy - methods | Quality of Life | Female
Journal Article
Journal of Obstetrics and Gynaecology Canada (JOGC), ISSN 1701-2163, 2010, Volume 32, Issue 11, pp. 1049 - 1055
Abstract Introduction Ovarian cancer is deadly and frequently affects older patients. In the next 20 years, the number of patients over 65 will double, and... 
Obstetrics and Gynecology | cytoreduction | CA 125 | optimal surgery | Ovarian cancer | Cytoreduction | Optimal surgery | CA-125 Antigen - blood | Ovarian Neoplasms - diagnosis | Humans | Middle Aged | Survival Rate | Treatment Outcome | Ovarian Neoplasms - epidemiology | Aged, 80 and over | Aging | Adult | Female | Aged | Chemotherapy, Adjuvant | Ovarian Neoplasms - surgery
Journal Article
Journal of Obstetrics and Gynaecology Canada (JOGC), ISSN 1701-2163, 2009, Volume 31, Issue 1, pp. 54 - 56
Abstract Background Clear cell adenocarcinoma of the vagina is rare tumour that is usually treated aggressively. We report a case of clear cell adenocarcinoma... 
Obstetrics and Gynecology | sentinel lymph node mapping | Clear cell adenocarcinoma | Sentinel lymph node mapping | Adenocarcinoma, Clear Cell - surgery | Young Adult | Fertility | Humans | Female | Treatment Outcome | Vaginal Neoplasms - surgery
Journal Article
Journal of Obstetrics and Gynaecology Canada (JOGC), ISSN 1701-2163, 2011, Volume 33, Issue 3, pp. 280 - 288
Résumé Objectif Aider les fournisseurs de soins à comprendre la situation actuelle en matière de cancer du col utérin au sein des pays ne disposant que de... 
Obstetrics and Gynecology | mortality | resources | Human papillomavirus | screening | cervical cancer | testing
Journal Article